These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25311739)

  • 61. Epigenetic Achilles' heel of AML.
    Ueda K; Steidl U
    Nat Cancer; 2021 May; 2(5):481-483. PubMed ID: 35122022
    [No Abstract]   [Full Text] [Related]  

  • 62. Epigenomic Disruption of Cardiovascular Care: What It Will Take.
    Monte E; Fischer MA; Vondriska TM
    Circ Res; 2017 May; 120(11):1692-1693. PubMed ID: 28546346
    [No Abstract]   [Full Text] [Related]  

  • 63. Current and emerging technology approaches in genomics.
    Conley YP; Biesecker LG; Gonsalves S; Merkle CJ; Kirk M; Aouizerat BE
    J Nurs Scholarsh; 2013 Mar; 45(1):5-14. PubMed ID: 23294727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AML genomics: introduction.
    Graubert T
    Semin Hematol; 2014 Oct; 51(4):249. PubMed ID: 25311737
    [No Abstract]   [Full Text] [Related]  

  • 65. Biochemical, genomic, and epigenomic profiling of isolated cancer cell lines' micronuclei.
    Agustinus AS; Bakhoum S
    Methods Cell Biol; 2022; 172():51-66. PubMed ID: 36064226
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improving distance measures between genomic tracks with mutual proximity.
    Haschka T; Morlot JB; Carron L; Mozziconacci J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34308963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia.
    Alpár D; Egyed B; Bödör C; Kovács GT
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830811
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The beginning of the end of the beginning in cancer genomics.
    Steensma DP
    N Engl J Med; 2013 May; 368(22):2138-40. PubMed ID: 23634995
    [No Abstract]   [Full Text] [Related]  

  • 69. Genomic classification of acute myeloid leukaemia: An incessantly evolving concept.
    Gupta R
    Natl Med J India; 2016; 29(5):283-285. PubMed ID: 28098084
    [No Abstract]   [Full Text] [Related]  

  • 70. [Genomic and Epigenomic Analysis of Brain Tumor:Focus on Glioma].
    Mukasa A
    No Shinkei Geka; 2020 Feb; 48(2):103-115. PubMed ID: 32094309
    [No Abstract]   [Full Text] [Related]  

  • 71. Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications.
    Abedalthagafi M
    Front Oncol; 2021; 11():704397. PubMed ID: 34367989
    [No Abstract]   [Full Text] [Related]  

  • 72. Editorial: Genomic and epigenomic applications in animal and veterinary sciences.
    Baloch AR; Feugang JM; Rodríguez-Osorio N
    Front Vet Sci; 2023; 10():1167079. PubMed ID: 37020977
    [No Abstract]   [Full Text] [Related]  

  • 73. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
    Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L
    Blood; 2015 Jan; 125(4):600-5. PubMed ID: 25499761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.
    Bossi D; Cicalese A; Dellino GI; Luzi L; Riva L; D'Alesio C; Diaferia GR; Carugo A; Cavallaro E; Piccioni R; Barberis M; Mazzarol G; Testori A; Punzi S; Pallavicini I; Tosti G; Giacó L; Melloni G; Heffernan TP; Natoli G; Draetta GF; Minucci S; Pelicci P; Lanfrancone L
    Cancer Discov; 2016 Jun; 6(6):650-63. PubMed ID: 27179036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New insights in AML biology from genomic analysis.
    Perry AM; Attar EC
    Semin Hematol; 2014 Oct; 51(4):282-97. PubMed ID: 25311741
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integrating genomics into prognostic models for AML.
    Sanchez M; Levine RL; Rampal R
    Semin Hematol; 2014 Oct; 51(4):298-305. PubMed ID: 25311742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.
    Momparler RL; Côté S; Momparler LF; Idaghdour Y
    Clin Epigenetics; 2014; 6(1):19. PubMed ID: 25313314
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutation position within evolutionary subclonal architecture in AML.
    Welch JS
    Semin Hematol; 2014 Oct; 51(4):273-81. PubMed ID: 25311740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic alterations in acute myeloid leukemias.
    Mehdipour P; Santoro F; Minucci S
    FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.